Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 27 | 2024 | 369 | 6.140 |
Why?
|
| Nucleus Accumbens | 12 | 2023 | 42 | 3.980 |
Why?
|
| Opioid-Related Disorders | 4 | 2024 | 462 | 2.020 |
Why?
|
| Cocaine | 8 | 2023 | 86 | 1.950 |
Why?
|
| Fentanyl | 3 | 2024 | 69 | 1.860 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2024 | 116 | 1.720 |
Why?
|
| Sex Characteristics | 9 | 2021 | 198 | 1.680 |
Why?
|
| Analgesics, Opioid | 8 | 2024 | 488 | 1.570 |
Why?
|
| Sleep | 4 | 2024 | 217 | 1.470 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 688 | 1.340 |
Why?
|
| Ethanol | 9 | 2020 | 304 | 1.280 |
Why?
|
| Reward | 8 | 2022 | 80 | 1.160 |
Why?
|
| Mice, Inbred C57BL | 13 | 2024 | 3168 | 1.130 |
Why?
|
| Animals | 44 | 2024 | 19519 | 1.130 |
Why?
|
| Corpus Striatum | 4 | 2024 | 96 | 1.100 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 215 | 1.070 |
Why?
|
| Mice | 28 | 2024 | 10210 | 1.010 |
Why?
|
| Period Circadian Proteins | 3 | 2015 | 71 | 1.000 |
Why?
|
| Motor Activity | 7 | 2015 | 342 | 0.980 |
Why?
|
| Glycerides | 1 | 2024 | 11 | 0.940 |
Why?
|
| Arachidonic Acids | 1 | 2024 | 23 | 0.930 |
Why?
|
| Endocannabinoids | 1 | 2024 | 20 | 0.920 |
Why?
|
| Circadian Clocks | 3 | 2017 | 44 | 0.880 |
Why?
|
| Chronobiology Disorders | 2 | 2014 | 5 | 0.870 |
Why?
|
| Brain | 8 | 2023 | 1477 | 0.860 |
Why?
|
| Stress, Psychological | 2 | 2019 | 439 | 0.860 |
Why?
|
| Prefrontal Cortex | 5 | 2023 | 112 | 0.860 |
Why?
|
| Alcohol Drinking | 6 | 2018 | 294 | 0.840 |
Why?
|
| Hormones | 2 | 2021 | 57 | 0.810 |
Why?
|
| Analgesia | 1 | 2022 | 31 | 0.800 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 131 | 0.780 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2022 | 124 | 0.760 |
Why?
|
| Sleep Wake Disorders | 3 | 2024 | 67 | 0.740 |
Why?
|
| Valproic Acid | 1 | 2020 | 25 | 0.720 |
Why?
|
| Male | 36 | 2024 | 27346 | 0.690 |
Why?
|
| Nerve Tissue Proteins | 6 | 2022 | 422 | 0.690 |
Why?
|
| Sirtuin 1 | 3 | 2022 | 23 | 0.680 |
Why?
|
| Aggression | 1 | 2019 | 57 | 0.660 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 259 | 0.650 |
Why?
|
| Fibroblasts | 1 | 2021 | 366 | 0.650 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 5 | 0.650 |
Why?
|
| Neurons | 5 | 2024 | 854 | 0.640 |
Why?
|
| Transcription Factors | 4 | 2022 | 1453 | 0.630 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 36 | 0.610 |
Why?
|
| Depression | 3 | 2024 | 856 | 0.610 |
Why?
|
| Brain Diseases | 1 | 2019 | 67 | 0.600 |
Why?
|
| Longevity | 1 | 2019 | 111 | 0.590 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 83 | 0.560 |
Why?
|
| Antipsychotic Agents | 4 | 2024 | 313 | 0.550 |
Why?
|
| Dopamine | 3 | 2022 | 101 | 0.540 |
Why?
|
| beta-Endorphin | 2 | 2015 | 8 | 0.520 |
Why?
|
| Anxiety | 3 | 2020 | 395 | 0.520 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2015 | 22 | 0.490 |
Why?
|
| Schizophrenia | 3 | 2022 | 256 | 0.470 |
Why?
|
| Spleen | 2 | 2013 | 485 | 0.460 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1535 | 0.460 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 141 | 0.450 |
Why?
|
| Humans | 29 | 2024 | 58964 | 0.440 |
Why?
|
| CLOCK Proteins | 4 | 2018 | 45 | 0.440 |
Why?
|
| Transcriptome | 6 | 2024 | 319 | 0.430 |
Why?
|
| Granzymes | 1 | 2013 | 17 | 0.430 |
Why?
|
| Wakefulness | 2 | 2024 | 38 | 0.430 |
Why?
|
| Perforin | 1 | 2013 | 29 | 0.430 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 164 | 0.430 |
Why?
|
| Female | 21 | 2024 | 30640 | 0.420 |
Why?
|
| Dopaminergic Neurons | 3 | 2021 | 31 | 0.410 |
Why?
|
| Proteome | 2 | 2023 | 135 | 0.410 |
Why?
|
| Psychotic Disorders | 2 | 2024 | 150 | 0.400 |
Why?
|
| Behavior | 1 | 2012 | 38 | 0.390 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 174 | 0.380 |
Why?
|
| Rats | 7 | 2021 | 1904 | 0.370 |
Why?
|
| Interferon-gamma | 1 | 2013 | 536 | 0.370 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 33 | 0.360 |
Why?
|
| Immune System | 1 | 2011 | 129 | 0.350 |
Why?
|
| Computational Biology | 1 | 2012 | 323 | 0.340 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 695 | 0.330 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 75 | 0.320 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 51 | 0.310 |
Why?
|
| Biological Clocks | 3 | 2009 | 69 | 0.270 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 547 | 0.260 |
Why?
|
| Glutamic Acid | 3 | 2022 | 98 | 0.260 |
Why?
|
| Locomotion | 3 | 2021 | 108 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 150 | 0.250 |
Why?
|
| Behavior, Animal | 2 | 2018 | 214 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2046 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2012 | 763 | 0.230 |
Why?
|
| Central Nervous System Depressants | 4 | 2015 | 42 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 671 | 0.220 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 113 | 0.220 |
Why?
|
| Ketamine | 1 | 2023 | 33 | 0.210 |
Why?
|
| Morphine | 1 | 2023 | 52 | 0.210 |
Why?
|
| Metformin | 1 | 2024 | 67 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2024 | 246 | 0.210 |
Why?
|
| Aging | 2 | 2021 | 720 | 0.210 |
Why?
|
| Periodicity | 1 | 2023 | 50 | 0.210 |
Why?
|
| Hyperalgesia | 1 | 2022 | 13 | 0.210 |
Why?
|
| Drug Tolerance | 1 | 2022 | 28 | 0.210 |
Why?
|
| Cytokines | 2 | 2021 | 903 | 0.200 |
Why?
|
| Arousal | 1 | 2022 | 42 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 320 | 0.200 |
Why?
|
| NAD | 2 | 2022 | 45 | 0.200 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 77 | 0.190 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 32 | 0.190 |
Why?
|
| Analgesics | 1 | 2022 | 100 | 0.190 |
Why?
|
| Electroencephalography | 1 | 2022 | 134 | 0.190 |
Why?
|
| Hypothalamus | 2 | 2012 | 120 | 0.190 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2021 | 1 | 0.190 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 2 | 0.190 |
Why?
|
| Eye Movements | 1 | 2022 | 80 | 0.190 |
Why?
|
| Astrocytes | 1 | 2022 | 113 | 0.190 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 13 | 0.190 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2021 | 32 | 0.190 |
Why?
|
| Glucagon | 1 | 2021 | 34 | 0.190 |
Why?
|
| Genetics | 1 | 2021 | 13 | 0.190 |
Why?
|
| Models, Biological | 4 | 2017 | 1137 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 32 | 0.180 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Mutation | 3 | 2020 | 2420 | 0.180 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 68 | 0.180 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 31 | 0.180 |
Why?
|
| Neurosciences | 1 | 2021 | 28 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2023 | 397 | 0.180 |
Why?
|
| Species Specificity | 3 | 2020 | 335 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2021 | 67 | 0.170 |
Why?
|
| Insulin | 3 | 2023 | 682 | 0.170 |
Why?
|
| Drinking | 2 | 2018 | 14 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 522 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2012 | 591 | 0.170 |
Why?
|
| Software | 1 | 2023 | 364 | 0.170 |
Why?
|
| Pain | 1 | 2022 | 406 | 0.160 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 156 | 0.160 |
Why?
|
| Social Behavior | 1 | 2019 | 88 | 0.160 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 24 | 0.150 |
Why?
|
| Clozapine | 1 | 2018 | 30 | 0.150 |
Why?
|
| Genotype | 1 | 2020 | 641 | 0.150 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 14 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 140 | 0.150 |
Why?
|
| Synapses | 1 | 2019 | 177 | 0.140 |
Why?
|
| Lithium | 1 | 2017 | 13 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 301 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 880 | 0.130 |
Why?
|
| Norepinephrine | 2 | 2021 | 99 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2016 | 69 | 0.130 |
Why?
|
| Fasting | 1 | 2015 | 50 | 0.130 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 681 | 0.130 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 22 | 0.130 |
Why?
|
| Self Administration | 3 | 2020 | 46 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 254 | 0.130 |
Why?
|
| Lithium Chloride | 1 | 2015 | 1 | 0.130 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 150 | 0.120 |
Why?
|
| Corticosterone | 1 | 2015 | 21 | 0.120 |
Why?
|
| Body Temperature | 1 | 2015 | 44 | 0.120 |
Why?
|
| Antimanic Agents | 1 | 2015 | 29 | 0.120 |
Why?
|
| Running | 1 | 2015 | 80 | 0.120 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 139 | 0.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.120 |
Why?
|
| Maze Learning | 1 | 2015 | 51 | 0.120 |
Why?
|
| Restraint, Physical | 1 | 2015 | 31 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 34 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 183 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 171 | 0.120 |
Why?
|
| Amygdala | 1 | 2015 | 78 | 0.120 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 253 | 0.120 |
Why?
|
| Inflammation | 1 | 2021 | 1096 | 0.120 |
Why?
|
| Adolescent | 3 | 2024 | 5879 | 0.110 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 25 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2015 | 467 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 304 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 51 | 0.100 |
Why?
|
| Photoperiod | 1 | 2012 | 40 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 846 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 30 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 26 | 0.100 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 109 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 191 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 280 | 0.090 |
Why?
|
| Sympathectomy, Chemical | 1 | 2010 | 1 | 0.090 |
Why?
|
| Guanethidine | 1 | 2010 | 3 | 0.090 |
Why?
|
| Sympatholytics | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 148 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 3551 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 569 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 630 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 21 | 0.080 |
Why?
|
| Pregnancy | 1 | 2015 | 2334 | 0.070 |
Why?
|
| RNA | 1 | 2010 | 400 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1219 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1048 | 0.060 |
Why?
|
| Cosmetics | 1 | 2005 | 17 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 25 | 0.060 |
Why?
|
| Seizures | 1 | 2005 | 117 | 0.060 |
Why?
|
| Alcoholism | 2 | 2024 | 306 | 0.060 |
Why?
|
| Suicide, Attempted | 1 | 2024 | 101 | 0.060 |
Why?
|
| Fear | 1 | 2023 | 64 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 58 | 0.050 |
Why?
|
| Brain Stem | 1 | 2021 | 30 | 0.050 |
Why?
|
| Hippocampus | 1 | 2023 | 238 | 0.050 |
Why?
|
| Rotenone | 1 | 2021 | 9 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 109 | 0.050 |
Why?
|
| Insecticides | 1 | 2021 | 29 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 16 | 0.050 |
Why?
|
| Glucose | 1 | 2024 | 440 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 58 | 0.050 |
Why?
|
| Rodentia | 1 | 2020 | 19 | 0.050 |
Why?
|
| Synaptic Vesicles | 1 | 2020 | 26 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 146 | 0.040 |
Why?
|
| Anhedonia | 1 | 2020 | 7 | 0.040 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 5 | 0.040 |
Why?
|
| Light | 2 | 2015 | 200 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 60 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 94 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 288 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 547 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 76 | 0.040 |
Why?
|
| Affect | 1 | 2020 | 121 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 15640 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 37 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 56 | 0.040 |
Why?
|
| Drosophila | 1 | 2021 | 419 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 103 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2018 | 119 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 207 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 79 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2450 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1303 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2017 | 80 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 770 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 158 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 35 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 252 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 805 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 291 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1983 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 217 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 550 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 435 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2429 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 982 | 0.030 |
Why?
|
| alpha-MSH | 1 | 2012 | 4 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 5 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2090 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 30 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 790 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 229 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 68 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7451 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 16172 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1517 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 576 | 0.020 |
Why?
|
| Triazolam | 1 | 2007 | 4 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 93 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 146 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2007 | 90 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 71 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 79 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 376 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5057 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4284 | 0.020 |
Why?
|
| Camphor | 1 | 2005 | 1 | 0.020 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 2 | 0.020 |
Why?
|
| Activity Cycles | 1 | 2005 | 3 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2005 | 168 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1512 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 13250 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1817 | 0.010 |
Why?
|